Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor;Exacerbation d'un syndrome douloureux chronique diffus par l'introduction d'un inhibiteur de l'aromatase

Praxis

Volumn 97, Issue 3, 2008, Pages 137-141

  Nemitz, N ^a   Kurmann, P T ^a   Van Linthoudt, Daniel ^a  

^a Hopital de la Chaux de Fonds   (Switzerland)

Author keywords

Aromatase; Arthralgia; Breast cancer; Estrogens; Pain

Indexed keywords

EID: 39349117641     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.97.3.137     Document Type: Short Survey

References (50)

1. Early Breast Cancer Trialists' Collaboration Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 339: 71-85.
2. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998; 351: 1451-67.
3. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995; 92: 3650-7.
4. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996; 36: 203-32. (Pubitemid 26168699)
5. Clemons M, Goss P. Estrogen and the risk of breast cancer.N Engl J Med 2001; 344: 276-85. (Pubitemid 32108534)
6. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993; 15: 17-35. (Pubitemid 23269068)
7. Shoker BS, Jarvis C, Sibson DR,Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999; 188: 237-44. (Pubitemid 29317764)
8. Santen RJ, Leszczynski D,Tilson-Mallet N, et al. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann N Y Acad Sci 1986; 464: 126-37. (Pubitemid 17197627)
9. Wakeling AE,Valacaccia B, Newboult E, Green LR, Non-steroidal anti-oestrogensrecepor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J Steroid Biochem 1984; 20: 111-20. (Pubitemid 14127411)
10. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex,Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005; 365: 60-2.
11. Mouridsen HT, Robert NJ. Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer. Medscape gen med 2005; 7: 20.
12. Goss PE, Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 2001; 19: 881-94. (Pubitemid 32119104)
13. Hamilton A, Piccart M. The third generation non-steroidal aromatase inhibitors: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer. Ann Oncol 1999; 10: 377-84. (Pubitemid 29236413)
14. Goss PE, Ingle JN,Martino S, et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17. J Nat Cancer Inst 2005; 97: 1262-71. (Pubitemid 41535367)
15. Mouridsen HT. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women. Curr Med Res Opin 2006; 22: 1609-21. (Pubitemid 44297439)
16. Venturini M, Del Mastro L. Safety of adjuvant aromatase inhibitor therapy. Cancer Treat Rev 2006; 32: 548-56. (Pubitemid 44464139)
17. Felson DT, Cummings SR. Aromatase Inhibitors and the Syndrome of Arthralgias with estrogens deprivation. Arthritis Rheum 2005; 52: 2594-8. (Pubitemid 41369086)
18. Donnellan PP, Douglas SL, Cameron DA, Leonard RC. Aromatase inhibitors and arthralgia. J Clin Oncol 2001; 19: 2767.
19. Fillingim RB, Ness TJ. Sex related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev 2000; 24:485-501. (Pubitemid 30243063)
20. McMahon SB. NGF as a mediator of inflammatory pain. Philos Trans R Soc Lond B Biol Sci 1996; 351: 431-40. (Pubitemid 126745351)
21. Woolf CJ. Phenotypic modification of primary sensory neurons : the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci 1996; 351: 441-8. (Pubitemid 126745352)
22. Sohrabji F, Miranda RC,Toran-Allerand CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994; 14: 459-71. (Pubitemid 24043906)
23. Zimmermann M, Herdegen T. Plasticity of the nervous system at the systemic, cellular, and molecular levels: a mecanism of chronic pain and hyperalgesia. In: Carli G, Zimmermann M, editors. Towards the neurobiology of chronic pain, Amsterdam: Elsevier, 1996: 233-59. (Pubitemid 27048991)
24. Liuzzi FJ, Scoville SA, Bufton SM. Long-term estrogen replacement coordinately decreases trkA and beta-PPT mRNA levels in dorsal root ganglion neurons. Exp Neurol 1999; 155: 260-7. (Pubitemid 29124719)
25. Blomquist A. Sex Hormones and Pain: A new role for brain aromatase? Commentary. J Comp Neurol 2000; 423: 549-51.
26. Evrard H, Baillien M, Froidart A, Absil P, Harada N, Balthazard J. Localization and controls of aromatase in the quail spinal cord. J Comp Neurol 2000; 423: 552-64. (Pubitemid 30452620)
27. Duval P, Lenoir V, Moussaoui S, Garret C, Kerdelhue B. Substance P and neurokinin A variations throughout the rat estrous cycle; comparison with ovariectomized and male rats. J Neurosci Res 1996; 45: 610-6. (Pubitemid 26293361)
28. Kerdelhue B,Tartar A, Lenoir V, el Abed A, Hublau P, Millar RP. Binding studies of substance P anterior pituitary binding sites during rat estrous cycle. Regulatory Peptides 1985; 10: 133-43. (Pubitemid 15115424)
29. Smith SS. Female sex steroid hormones: from receptors to networks to performance-actions on the sensorimotor system. Prog Neurobiol 1994; 44: 55-86.
30. Gazzaley AH,Weiland NG, McEwen BS, Morrison JH. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci 1996; 16: 6830-8. (Pubitemid 26359365)
31. Morley BJ, Rodriguez-Sierra JF, Clough RW. Increase in hypothalamic nicotinic acetylcholine receptors in prepuberal female rats administered estrogen. Brain Res 1983; 278: 262-5. (Pubitemid 14219300)
32. Daniel JM. Effects of oestrogen on cognition: what have we learned from basic research ? J Neuroendocrinol 2006; 18: 787-95. (Pubitemid 44340515)
33. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89: 484-90. (Pubitemid 15040918)
34. Henderson,VW. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med 1997; 103: 11-8.
35. Eisenach JC, Hood DD. Sex differencies in analgesia from intrathecal neostigmine in humans. Anesthesiology 1998; 89: A1106.
36. McEwen BS, Alves SE, Bulloch K,Weil NG. Clinically relevant basic science studies of gender differencies and sex hormone effects. Psychopharm Bull 1998; 34: 251-9. (Pubitemid 28537940)
37. Lavand'homme PM, Pan HL, Eisenach JC. Sex differencies in spinal cholinergic analgesia following capsaicin. Anesthesiology 1998; 89: A1170.
38. Kidd BL, Photiou A, Inglis J. The role of inflammatory mediators on nociception and pain in arthritis. Novartis Found Symp 2004; 260: 122-33.
39. Salem ML. Estrogens, A double-edged sword : modulation of TH1- et TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 2004; 3: 97-104. (Pubitemid 38854894)
40. Del Junco DJ, Annegers JF, Luthra HS. Do oral contraceptives prevent rheumatoid arthritis? JAMA 1985; 254: 1938-41. (Pubitemid 15249095)
41. Sylvest AO. Rheumatoid arthritis and the pill. Report of two cases. Ugeskr Laeger 1969; 131: 1480-1.
42. Le Bail J, Liagre B,Vergne P, et al. Aromatase in synovial cells from postmenopausal women. Steroids 2001; 66: 749-57. (Pubitemid 32755772)
43. Riley JL, Robinson ME,Wise EA,Myers CD, Fillingim RB. Sex differences in the perception of noxious experimental stimuli: a metaanalysis. Pain 1998; 74: 181-7. (Pubitemid 28081604)
44. Riley JL, Robinson ME,Wise EA, Price DD. A meta-analytic review of pain perception across the menstrual cycle. Pain 1999; 81: 225-35. (Pubitemid 29257893)
45. Ho SC, Chan SG, Yip YB, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptoms clustering in Chinese women. Maturitas 1999; 33: 219-27.
46. Musgrave DS,Vogt MT,Nevitt MC, Cauley JA. Back problems among postmenopausal women taking estrogen replacement therapy. Spine 2001; 26: 1606-12. (Pubitemid 32646136)
47. Cutolo M. Estrogen metabolites : increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2004; 31: 419-21. (Pubitemid 38337597)
48. Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.N Engl J Med 2004; 350: 1081-92. (Pubitemid 38298988)
49. Wheler J, Johnson M, Seidman A. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy. Semin Oncol 2006; 33: 672-80. (Pubitemid 44828129)
50. Balthazart J, Ball GF.New insights into the regulation and function of brain estrogen synthase (aromatase). Trends Neurosc 1998; 21: 243-9. (Pubitemid 28239981)